Profilo
Michelle Gates is currently Chief People Officer at CAMP4 Therapeutics Corp.
since 2021.
Formerly, Ms. Gates was Vice President-Human Resources at Akamai Technologies, Inc. from 2005 to 2021, Human Resources Manager at Teradyne, Inc. from 2004 to 2005, and Human Resources Director at British Telecommunications Ltd. from 2001 to 2004.
Ms. Gates completed undergraduate education at Providence College.
Posizioni attive di Michelle Gates
| Società | Posizione | Inizio |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Ufficiale delle Risorse Umane | 01/06/2021 |
Precedenti posizioni note di Michelle Gates
| Società | Posizione | Fine |
|---|---|---|
| AKAMAI TECHNOLOGIES, INC. | Ufficiale delle Risorse Umane | 01/06/2021 |
| TERADYNE, INC. | Ufficiale delle Risorse Umane | 01/01/2005 |
British Telecommunications Plc
British Telecommunications Plc Major TelecommunicationsCommunications Provides telecommunication services | Ufficiale delle Risorse Umane | 01/01/2004 |
Formazione di Michelle Gates
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Teradyne, Inc.
Teradyne, Inc. Electronic Production EquipmentElectronic Technology Designs, manufactures, markets and services electronic test systems | Electronic Technology |
Akamai Technologies, Inc.
Akamai Technologies, Inc. Data Processing ServicesTechnology Services Provides cloud computing, security and content delivery services | Technology Services |
British Telecommunications Plc
British Telecommunications Plc Major TelecommunicationsCommunications Provides telecommunication services | Communications |
Providence College
Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
















